Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
1.
Rev. cuba. med ; 59(4): e1435, oct.-dic. 2020. graf
Article in Spanish | LILACS, CUMED | ID: biblio-1144511

ABSTRACT

Introducción: La linfangioleiomiomatosis pulmonar constituye un desafío, tanto en su manejo diagnóstico como en la atención de sus complicaciones. Es una enfermedad rara que se caracteriza por la proliferación del músculo liso alrededor de las estructuras bronco-vasculares, linfáticos y en el intersticio pulmonar, unido a la dilatación quística de los espacios aéreos terminales. Objetivo: Describir la evolución clínica y el tratamiento de un paciente con linfangioleiomiomatosis pulmonar. Presentación de caso: Se presenta un caso de linfangioleiomiomatosis pulmonar que desde el punto de vista clínico se manifestó por neumotórax a repetición. Se llegó a diagnóstico definitivo mediante la realización de una biopsia de pulmón. Desarrollo: La linfangioleiomiomatosis es una entidad rara que afecta fundamentalmente a mujeres en edad fértil y que se caracteriza por la presencia de un patrón quístico difuso. Su prevalencia e incidencia es desconocida. Conclusiones: Se puede concluir que la presencia de neumotórax espontáneo o recidivante en una mujer en edad fértil, o embarazada, debe sospecharse linfangioleiomiomatosis(AU)


Introduction: Pulmonary lymphangioleiomyomatosis constitutes a challenge, both in its diagnostic management and in the care of complications. It is a rare disease characterized by the proliferation of smooth muscle around the bronchovascular and lymphatic structures and in the pulmonary interstitium, together with cystic dilation of the terminal air spaces. Objective: To describe a diagnosed case of pulmonary lymphangioleiomyomatosis. Case report: A case of pulmonary lymphangioleiomyomatosis is reported, which was clinically showed as recurrent pneumothorax. A definitive diagnosis was reached by performing a lung biopsy. Discussion: Lymphangioleiomyomatosis is a rare entity that mainly affects women of childbearing age and is characterized by the presence of a diffuse cystic pattern. Its prevalence and incidence is unknown. Conclusions: It can be concluded that the presence of spontaneous or recurrent pneumothorax in a woman of childbearing age, or pregnant, should be suspected lymphangioleiomyomatosis(AU)


Subject(s)
Humans , Female , Adult , Pneumothorax/complications , Lymphangioleiomyomatosis/diagnosis , Lymphangioleiomyomatosis/mortality , Lymphangioleiomyomatosis/pathology
2.
Article in English | IMSEAR | ID: sea-157402

ABSTRACT

Lymphangioleiomyomatosis (LAM) is a progressive disease affecting women of childbearing age. It is microscopically characterized by abnormal smooth muscle proliferation in the walls of lymphatics and lymph nodes. A 52-year old female presented with pain in left leg and bilateral pedal oedema. USG and CT abdomen revealed a retroperitoneal cystic mass suspicious of malignancy. Retroperitoneal exploration was done and the mass was excised which revealed milky contents within. On gross examination of the specimen, a spongy mass was noted . Histopathological examination led to a diagnosis of lymphangioleiomyomatosis. LAM is a rare disease unfamiliar to many physicians and may pose a diagnostic dilemma to the physician, possibly resulting in delayed or missed diagnosis . Many treatment modalities including corticosteroids, cytotoxic drugs, chemotherapy, radiation and hormonal therapy are suggested. The prognosis of LAM varies with the individual, but many patients respond well to intramuscular medroxyprogesterone injections.


Subject(s)
Cell Proliferation , Diagnostic Errors , Female , Humans , Leg/pathology , Lymphangioleiomyomatosis/complications , Lymphangioleiomyomatosis/diagnosis , Lymphangioleiomyomatosis/drug therapy , Lymphangioleiomyomatosis/pathology , Lymphangioleiomyomatosis/radiotherapy , Lymphangioleiomyomatosis/therapy , Muscle, Smooth, Vascular/pathology , Retroperitoneal Space
3.
J. bras. pneumol ; 37(4): 424-430, jul.-ago. 2011. ilus, tab
Article in Portuguese | LILACS | ID: lil-597193

ABSTRACT

OBJETIVO: A linfangioleiomiomatose (LAM) é caracterizada pela presença de cistos pulmonares, cuja formação está associada à hiperreatividade de metaloproteinases de matriz (MMP), principalmente MMP-2 e MMP-9. Objetivamos comparar os níveis dessas MMPs entre pacientes com LAM e controles saudáveis, assim como avaliar, nas pacientes com LAM, a segurança e a eficácia do tratamento com doxiciclina, um potente inibidor de MMPs. MÉTODOS: Estudo clínico prospectivo no qual as pacientes com LAM receberam doxiciclina (100 mg/dia) por seis meses, coletando-se amostras de urina e sangue para a dosagem de MMP-2 e MMP-9 antes e ao final do período. Foram ainda obtidas amostras de 10 mulheres saudáveis. RESULTADOS: De 41 pacientes com LAM que iniciaram o tratamento, 34 concluíram o protocolo. Os níveis de MMP-9 sérica e urinária foram significativamente inferiores no grupo controle (p < 0,0001). Comparando-se os valores antes e após o tratamento, a mediana do nível sérico da MMP-9 reduziu de 919 ng/mL para 871 ng/mL (p = 0,05), enquanto a mediana da dosagem urinária de MMP-9 diminui de 11.558 pg/mL para 7.315 pg/mL (p = 0,10). A mediana da MMP-2 sérica apresentou um decréscimo significativo após o tratamento (p = 0,04). Não foram detectados níveis de MMP-2 urinária. Epigastralgia, náuseas e diarreia foram os efeitos adversos mais prevalentes, e geralmente autolimitados. Apenas 1 paciente interrompeu o tratamento devido a efeitos colaterais. CONCLUSÕES: Pela primeira vez, conseguiu-se evidenciar em pacientes com LAM a redução dos níveis séricos e urinários de MMPs após o uso de doxiciclina, que se mostrou uma medicação segura, com efeitos colaterais leves e toleráveis.


OBJECTIVE: Lymphangioleiomyomatosis (LAM) is characterized by lung cysts, whose development is associated with matrix metalloproteinase (MMP) hyperactivity, principally that of MMP-2 and MMP-9. Our objective was to compare LAM patients and controls in terms of the levels of these MMPs, as well as to determine the safety and efficacy of treatment with doxycycline, a potent MMP inhibitor. METHODS: Prospective clinical study involving female LAM patients who received doxycycline (100 mg/day) for six months. Urine and blood samples were collected for the quantification of MMP-2 and MMP-9 before and after the treatment period. Samples from 10 healthy women were also collected. RESULTS:Of the 41 LAM patients who started the treatment, 34 completed the protocol. Serum and urinary MMP-9 levels were significantly lower in the controls than in the LAM patients (p < 0.0001). Comparing pre- and post-treatment values, we found that the median level of MMP-9 in serum decreased from 919 ng/mL to 871 ng/mL (p = 0.05), whereas that of MMP-9 in urine decreased from 11,558 pg/mL to 7,315 pg/mL (p = 0.10). After treatment, the median level of MMP-2 in serum was significantly lower (p = 0.04) and urinary MMP-2 levels were undetectable. Nausea, diarrhea, and epigastric pain were the most prevalent adverse affects and were often self-limiting. There was only one case in which the patient discontinued the treatment because of side effects. CONCLUSIONS: We have demonstrated, for the first time, a decrease in serum and urine levels of MMPs in LAM patients treated with doxycycline, which proved to be a safe medication, with mild and well-tolerated side effects.


Subject(s)
Adult , Female , Humans , Angiogenesis Inhibitors/therapeutic use , Anti-Bacterial Agents/therapeutic use , Doxycycline/therapeutic use , Lung Neoplasms/drug therapy , Lymphangioleiomyomatosis/drug therapy , Matrix Metalloproteinases/antagonists & inhibitors , Angiogenesis Inhibitors/pharmacology , Anti-Bacterial Agents/pharmacology , Case-Control Studies , Doxycycline/pharmacology , Lung Neoplasms/blood , Lung Neoplasms/pathology , Lymphangioleiomyomatosis/blood , Lymphangioleiomyomatosis/pathology , Matrix Metalloproteinases/blood , Matrix Metalloproteinases/urine , Prospective Studies , Protease Inhibitors/therapeutic use
4.
Rev. méd. Chile ; 137(11): 1474-1477, nov. 2009. ilus
Article in Spanish | LILACS | ID: lil-537011

ABSTRACT

Lymphangioleiomyomatosis (LAM) is a rare interstitial lung disease, of unknown etiology, affecting almost exclusively women. Microscopically LAM consists of a diffuse proliferation of smooth muscle cells. LAM can occur without evidence of other diseases (sporadic LAM) or in conjunction with tuberous sclerosis complex (TSC). It presents with progressive breathlessness or with recurrent pneumothorax or chylothorax. We report a 33 year-old woman with a history of recurrent pneumothorax. Computed tomography (CT) scans showed numerous thin-walled cysts throughout the lungs, a characteristic finding in LAM. A pulmonary biopsy was compatible with the diagnosis and HMB-45 monoclonal antibodies were positive. Treatment with Sirolimus was started.


Subject(s)
Adult , Female , Humans , Lung Diseases, Interstitial/pathology , Lung Neoplasms/pathology , Lymphangioleiomyomatosis/pathology , Antibodies, Monoclonal/analysis , Lung Neoplasms/complications , Lymphangioleiomyomatosis/complications , Pneumothorax/etiology , Recurrence
6.
J. bras. pneumol ; 33(2): 229-233, mar.-abr. 2007. ilus
Article in Portuguese | LILACS | ID: lil-459296

ABSTRACT

A linfangiomatose, doença rara e de origem controversa, ocorre em indivíduos de todas as faixas etárias, predominando entre os mais jovens, sem predileção por sexo. Comumente cursa com envolvimento torácico, porém órgãos como ossos, baço e fígado podem ser acometidos. Histologicamente, o envolvimento pulmonar cursa com proliferação, anastomoses complexas e dilatação secundária do sistema linfático. Clinicamente, a apresentação é variável. Os achados radiográficos podem ser sugestivos e o diagnóstico é definido pela histologia. Relatamos dois casos da doença; uma das pacientes era oligossintomática e encontra-se em tratamento; na outra, a doença foi mais agressiva e o diagnóstico muito tardio, culminando em óbito.


Lymphangiomatosis, a rare diseases of controversial origin, occurs in individuals of any age, regardless of gender, but is predominantly seen in younger individuals. It often presents with thoracic involvement, although, the bones, spleen and liver can also be affected. Histologically, the pulmonar involvement includes proliferation, complex anastomoses and secondary dilatation of the lymphatic vessels. Clinically, the presentation is variable. Although radiographic findings can be suggestive of the disease, the final diagnosis is made histologically. We report two cases of lymphangiomatosis, both in females: one was oligosymptomatic and is being treated for the disease; the other had a more progressive form, was diagnosed quite late and ultimately died of the disease.


Subject(s)
Adult , Female , Humans , Lymphangioleiomyomatosis/diagnosis , Angiogenesis Inhibitors/therapeutic use , Biopsy , Diagnostic Imaging , Fatal Outcome , Immunohistochemistry , Interferon-alpha/therapeutic use , Lymphangioleiomyomatosis/drug therapy , Lymphangioleiomyomatosis/pathology , Lymphangioleiomyomatosis , Lymphatic System/pathology , Pleural Effusion
8.
Pulmäo RJ ; 13(1): 49-53, jan.-mar. 2004. ilus, tab
Article in Portuguese | LILACS | ID: lil-401689

ABSTRACT

Linfangioleiomiomatose (LAM) é uma doença rara, de etiologia desconhecida e que ocorre quase exclusivamente em mulheres em idade fértil. Os achados patológicos cardinais são a proliferação não-neoplásica de células imaturas de músculo liso e a formação de cistos pulmonares de paredes finas. Os autores descrevem um caso de LAM pulmonar e pneumotórax espontâneo bilateral em paciente com infecção pelo HIV


Subject(s)
Humans , Female , Adult , HIV Infections/complications , Lymphangioleiomyomatosis/complications , Pneumothorax/complications , Lymphangioleiomyomatosis/pathology , Lymphangioleiomyomatosis/drug therapy , Medroxyprogesterone , Tamoxifen/therapeutic use
9.
West Indian med. j ; 52(3): 250-252, Sept. 2003.
Article in English | LILACS | ID: lil-410710

ABSTRACT

A case of pulmonary lymphangioleiomyomatosis (PLAM) occurring in a 48-year-old Jamaican female is presented. The clinical, radiological, and pathological findings are typical of this rare condition, and serve to emphasize the need for a high index of suspicion in order to make the diagnosis and commence therapy early in the course of the disease. The outlook for patients with PLAM continues to be poor


Subject(s)
Humans , Female , Middle Aged , Lymphangioleiomyomatosis/diagnosis , Lung Neoplasms/diagnosis , Diagnosis, Differential , Lymphangioleiomyomatosis/drug therapy , Lymphangioleiomyomatosis/pathology , Lung Neoplasms/drug therapy , Lung Neoplasms/pathology
10.
Rev. colomb. neumol ; 8(4): 212-5, nov. 1996. ilus, graf
Article in Spanish | LILACS | ID: lil-190578

ABSTRACT

La linfangioleiomiomatosis es una enfermedad rara con menos de 250 casos reportados en la literatura universal, que ocurre únicamente en mujeres, usualmente en edad reproductiva y que se caracteriza por la proliferación de células de musculo liso en tejido pulmonar y en los vasos linfáticos. Presentamos el caso de una mujer de 29 años, con disnea progresiva, tos con escasa espectoración y neumotórax espontáneo bilateral. El diagnóstico se realizó mediante biopsia pulmonar a cielo abierto, donde se encontró proliferación de haces de músculo liso los cuales se disponían preferentemente alrededor de las estructuras vasculares,bronquiales y septo alveolares. Comentamos los principales hallazgos clínicos, radiológicos e histopatológicos.


Subject(s)
Humans , Female , Adult , Lymphangioleiomyomatosis/classification , Lymphangioleiomyomatosis/complications , Lymphangioleiomyomatosis/diagnosis , Lymphangioleiomyomatosis/epidemiology , Lymphangioleiomyomatosis/etiology , Lymphangioleiomyomatosis/physiopathology , Lymphangioleiomyomatosis/pathology , Lymphangioleiomyomatosis/drug therapy , Lymphangioleiomyomatosis/therapy , Lymphangiomyoma , Lymphangiomyoma/classification , Lymphangiomyoma/complications , Lymphangiomyoma/diagnosis , Lymphangiomyoma/drug therapy , Lymphangiomyoma/epidemiology , Lymphangiomyoma/etiology , Lymphangiomyoma/pathology , Lymphangiomyoma/physiopathology , Lymphangiomyoma/therapy , Lung Neoplasms , Lung Neoplasms/classification , Lung Neoplasms/complications , Lung Neoplasms/diagnosis , Lung Neoplasms/drug therapy , Lung Neoplasms/epidemiology , Lung Neoplasms/etiology , Lung Neoplasms/mortality , Lung Neoplasms/pathology , Lung Neoplasms/physiopathology , Lung Neoplasms/metabolism , Lung Neoplasms/therapy
11.
Säo Paulo med. j ; 114(5): 1278-1281, Sep.-Oct. 1996.
Article in English | LILACS | ID: lil-320851

ABSTRACT

Systemic lymphangiomatosis is a rare disease characterized by the exageration of lymphatic channel proliferation, occurring in children and young adults. We describe an extremely rare case of congenital systemic lymphangiomatosis in a newborn who had ascitis and respiratory failure develop immediately after delivery. Death occurred during the first hour of life. Autopsy findings showed numerous cysts in soft tissues of the cervical area, mediastinum and diaphragm, and several other organs including the liver, spleen, thyroid and kidneys. The severe and diffuse involvement with cysts in both lungs by lymphangiomatosis was associated with poor prognosis and death in our case.


Subject(s)
Humans , Female , Infant, Newborn , Lymphangioleiomyomatosis/congenital , Fatal Outcome , Lymphangioleiomyomatosis/pathology
SELECTION OF CITATIONS
SEARCH DETAIL